Get started
Author

Hongmei Zheng

Observed name: Zheng, Hongmei
ORCID: 0009-0004-9864-3211
Observed ORCID: 0009-0004-9864-3211
OpenAlex ID: A5113239129
Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis
2025 · Zhengjun Jing, Wenqin Huang, et al. · Molecular Cancer · 49
PDF
Comprehensive results of ESG401, a TROP2-targeting ADC: Updated phase 1 analysis in advanced solid tumors.
2025 · Fei Ma, Fuming Qiu, et al. · Journal of Clinical Oncology · 4
The Critical Role of Inhibitor of Differentiation 4 in Breast Cancer: From Mammary Gland Development to Tumor Progression
2025 · Yuhang Song, Panshi Zhang, et al. · Cancer Medicine · 4
PDF
Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment
2025 · Xinhong Wu, Feng Yuan, et al. · BMC Cancer · 4
PDF
ESG401, a trophoblast cell-surface antigen 2 (TROP2) antibody drug conjugate (ADC), for the treatment of first-line metastatic triple negative breast cancer (mTNBC).
2024 · Fei Ma, Fuming Qiu, et al. · Journal of Clinical Oncology · 4
PDF
Updated efficacy of anti-TROP2 ADC ESG401 for first-line metastatic TNBC in phase 1b study.
2024 · Fei Ma, Fuming Qiu, et al. · Journal of Clinical Oncology · 1
Synergistic mechanical and therapeutic modulation of engineered tumor cell-derived microparticles for enhanced cancer treatment
2026 · Xiaojuan Zhang, Ke Zhang, et al. · Cell Reports Medicine
NRG‐1 Promotes Axon Regeneration of Dorsal Root Ganglion Neurons in Diabetic Rats via ITGB1/FAK/AKT Pathway
2025 · Peng Zhan, Hewei Xiong, et al. · International Journal of Genomics
PDF
minimal data set
2022 · Tang, Yaoxiang, Luo, Jiadi, et al. · Figshare
Works count: 9
Citation count: 66
H-index: 4
I10-index: 1
Year
Topic
Type